The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects

Antonio Girolami, Luigino De Marco, Luigi Virgolini, Renata Peruffo, Fabrizio Fabris

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Platelet aggregation by various inductors was studied in citrated and heparinized plasma of the following groups of subjects: Normal, hemophilia A, combined factor V and factor VIII deficiency, v. Willebrand's disease and congenital afibrinogenemia. The results may be summarized as follows: A platelet aggregation in citrated plasma 1) platelet aggregation by common inductors ADP, adrenalin and collagen was normal in all groups of subjects but for the patients with congenital afibrinogenemia in whom adrenalin induced aggregation was absent or markedly reduced whereas ADP and collagen gave slightly reduced or near normal aggregation curves. 2) platelet aggregation by ristocetin was normal in all groups of subjects but for v. Willebrand's disease in which it was absent. B platelet aggregation in heparinized plasma 1) platelet aggregation by common inductors resulted to be normal in all groups of subjects except in congenital afibrinogenemia. In this latter case the pattern was still mildly defective but here was an increased aggregation as compared to citrated plasma. These findings have been interpreted to indicate a potentiating effect of heparin with regard to common inductors. 2) platelet aggregation by ristocetin resulted to be absent in all groups of subjects investigated. The possible mechanism of action of the inhibitory effect exercised by heparin with regard to ristocetin is discussed.

Original languageEnglish
Pages (from-to)219-227
Number of pages9
JournalBlut
Volume31
Issue number4
DOIs
Publication statusPublished - 1975

Fingerprint

Ristocetin
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Factor VIII
Platelet Aggregation
Fibrinogen
Heparin
Hemorrhage
Afibrinogenemia
Hemophilia A
Adenosine Diphosphate
Epinephrine
Collagen
Factor V

ASJC Scopus subject areas

  • Hematology

Cite this

The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects. / Girolami, Antonio; De Marco, Luigino; Virgolini, Luigi; Peruffo, Renata; Fabris, Fabrizio.

In: Blut, Vol. 31, No. 4, 1975, p. 219-227.

Research output: Contribution to journalArticle

Girolami, Antonio ; De Marco, Luigino ; Virgolini, Luigi ; Peruffo, Renata ; Fabris, Fabrizio. / The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects. In: Blut. 1975 ; Vol. 31, No. 4. pp. 219-227.
@article{459d2e4e41d84cad98c84543f65b2d7b,
title = "The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects",
abstract = "Platelet aggregation by various inductors was studied in citrated and heparinized plasma of the following groups of subjects: Normal, hemophilia A, combined factor V and factor VIII deficiency, v. Willebrand's disease and congenital afibrinogenemia. The results may be summarized as follows: A platelet aggregation in citrated plasma 1) platelet aggregation by common inductors ADP, adrenalin and collagen was normal in all groups of subjects but for the patients with congenital afibrinogenemia in whom adrenalin induced aggregation was absent or markedly reduced whereas ADP and collagen gave slightly reduced or near normal aggregation curves. 2) platelet aggregation by ristocetin was normal in all groups of subjects but for v. Willebrand's disease in which it was absent. B platelet aggregation in heparinized plasma 1) platelet aggregation by common inductors resulted to be normal in all groups of subjects except in congenital afibrinogenemia. In this latter case the pattern was still mildly defective but here was an increased aggregation as compared to citrated plasma. These findings have been interpreted to indicate a potentiating effect of heparin with regard to common inductors. 2) platelet aggregation by ristocetin resulted to be absent in all groups of subjects investigated. The possible mechanism of action of the inhibitory effect exercised by heparin with regard to ristocetin is discussed.",
author = "Antonio Girolami and {De Marco}, Luigino and Luigi Virgolini and Renata Peruffo and Fabrizio Fabris",
year = "1975",
doi = "10.1007/BF01633505",
language = "English",
volume = "31",
pages = "219--227",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects

AU - Girolami, Antonio

AU - De Marco, Luigino

AU - Virgolini, Luigi

AU - Peruffo, Renata

AU - Fabris, Fabrizio

PY - 1975

Y1 - 1975

N2 - Platelet aggregation by various inductors was studied in citrated and heparinized plasma of the following groups of subjects: Normal, hemophilia A, combined factor V and factor VIII deficiency, v. Willebrand's disease and congenital afibrinogenemia. The results may be summarized as follows: A platelet aggregation in citrated plasma 1) platelet aggregation by common inductors ADP, adrenalin and collagen was normal in all groups of subjects but for the patients with congenital afibrinogenemia in whom adrenalin induced aggregation was absent or markedly reduced whereas ADP and collagen gave slightly reduced or near normal aggregation curves. 2) platelet aggregation by ristocetin was normal in all groups of subjects but for v. Willebrand's disease in which it was absent. B platelet aggregation in heparinized plasma 1) platelet aggregation by common inductors resulted to be normal in all groups of subjects except in congenital afibrinogenemia. In this latter case the pattern was still mildly defective but here was an increased aggregation as compared to citrated plasma. These findings have been interpreted to indicate a potentiating effect of heparin with regard to common inductors. 2) platelet aggregation by ristocetin resulted to be absent in all groups of subjects investigated. The possible mechanism of action of the inhibitory effect exercised by heparin with regard to ristocetin is discussed.

AB - Platelet aggregation by various inductors was studied in citrated and heparinized plasma of the following groups of subjects: Normal, hemophilia A, combined factor V and factor VIII deficiency, v. Willebrand's disease and congenital afibrinogenemia. The results may be summarized as follows: A platelet aggregation in citrated plasma 1) platelet aggregation by common inductors ADP, adrenalin and collagen was normal in all groups of subjects but for the patients with congenital afibrinogenemia in whom adrenalin induced aggregation was absent or markedly reduced whereas ADP and collagen gave slightly reduced or near normal aggregation curves. 2) platelet aggregation by ristocetin was normal in all groups of subjects but for v. Willebrand's disease in which it was absent. B platelet aggregation in heparinized plasma 1) platelet aggregation by common inductors resulted to be normal in all groups of subjects except in congenital afibrinogenemia. In this latter case the pattern was still mildly defective but here was an increased aggregation as compared to citrated plasma. These findings have been interpreted to indicate a potentiating effect of heparin with regard to common inductors. 2) platelet aggregation by ristocetin resulted to be absent in all groups of subjects investigated. The possible mechanism of action of the inhibitory effect exercised by heparin with regard to ristocetin is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0016767080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016767080&partnerID=8YFLogxK

U2 - 10.1007/BF01633505

DO - 10.1007/BF01633505

M3 - Article

C2 - 1080679

AN - SCOPUS:0016767080

VL - 31

SP - 219

EP - 227

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 4

ER -